Year-End Report

ALSTON & BIRD LLP for AMERICAN CLINICAL LABORATORY ASSOCIATION

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

"Anti-mark up" provisions related to billing and payment for laboratory services. H.R. 3453 & S. 2099, bills to repeal a competitive bidding demonstration project for clinical lab services. CMS issues related to the ordering, billing and payment for clinical laboratory testing. FDA regulation of clinical laboratory testing.

LobbyistCovered position, as disclosed
ERIN L DARLING —
PETER M KAZON N/A
TAMARA CARTY TENNEY N/A
TIFFANI WILLIAMS N/A

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 2099 (110th), H.R. 3453 (110th)

Medicare/Medicaid MMM

"Anti-mark up" provisions related to billing and payment for laboratory services. H.R. 3453 & S. 2099, bills to repeal a competitive bidding demonstration project for clinical lab services. CMS issues related to the ordering, billing and payment for clinical laboratory testing. FDA regulation of clinical laboratory testing.

LobbyistCovered position, as disclosed
ERIN L DARLING —
PETER M KAZON N/A
TAMARA CARTY TENNEY N/A
TIFFANI WILLIAMS N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 2099 (110th), H.R. 3453 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.